Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wai-Kay Seto

Showing results (51-60 of 326) with videos related to

Pageof 33
Sort By:
Clinics in Liver Disease|October 1, 2023
Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid PolymersLung-Yi Mak, Rex Wan-Hin Hui, Wai-Kay Seto, et al.
Alimentary Pharmacology & Therapeutics|August 20, 2025
Review Article: Impact of Alcohol Consumption on the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver DiseaseYunxuan Lei, Yixuan Zhu, Wenjing Ni, et al.
Clinical Liver Disease|April 16, 2024
Therapeutic advances in HBV cureRex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, et al.
Trends in Molecular Medicine|July 2, 2022
New strategies for the treatment of chronic hepatitis BLung-Yi Mak, Ka-Shing Cheung, James Fung, et al.
World Journal of Gastroenterology|January 1, 2014
Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infectionTao Lu, Wai-Kay Seto, Ran-Xu Zhu, et al.
Clinical and Translational Gastroenterology|September 1, 2017
Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015Ka-Shing Cheung, Wai-Kay Seto, James Fung, et al.
Clinical and Translational Gastroenterology|June 23, 2017
Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic AcidKa-Shing Cheung, Wai-Kay Seto, James Fung, et al.
Hepatology (Baltimore, Md.)|September 18, 2025
Reply: Technical considerations in the development of a multimodal deep learning model for predicting hepatocellular carcinoma outcomesRex Wan-Hin Hui, Keith Wan-Hang Chiu, Philip Leung-Ho Yu, et al.
Hepatology International|June 10, 2025
Emerging therapies for HBsAg seroclearance: spotlight on novel combination strategiesRex Wan-Hin Hui, James Fung, Wai-Kay Seto, et al.
Clinical and Molecular Hepatology|January 19, 2023
The role of different viral biomarkers on the management of chronic hepatitis BLung-Yi Mak, Rex Wan-Hin Hui, James Fung, et al.
Pageof 33

Showing results (51-60 of 326) with videos related to

Sort By:
Pageof 33
Clinics in Liver Disease|October 1, 2023
Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid PolymersLung-Yi Mak, Rex Wan-Hin Hui, Wai-Kay Seto, et al.
Alimentary Pharmacology & Therapeutics|August 20, 2025
Review Article: Impact of Alcohol Consumption on the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver DiseaseYunxuan Lei, Yixuan Zhu, Wenjing Ni, et al.
Clinical Liver Disease|April 16, 2024
Therapeutic advances in HBV cureRex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, et al.
Trends in Molecular Medicine|July 2, 2022
New strategies for the treatment of chronic hepatitis BLung-Yi Mak, Ka-Shing Cheung, James Fung, et al.
World Journal of Gastroenterology|January 1, 2014
Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infectionTao Lu, Wai-Kay Seto, Ran-Xu Zhu, et al.
Clinical and Translational Gastroenterology|September 1, 2017
Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015Ka-Shing Cheung, Wai-Kay Seto, James Fung, et al.
Clinical and Translational Gastroenterology|June 23, 2017
Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic AcidKa-Shing Cheung, Wai-Kay Seto, James Fung, et al.
Hepatology (Baltimore, Md.)|September 18, 2025
Reply: Technical considerations in the development of a multimodal deep learning model for predicting hepatocellular carcinoma outcomesRex Wan-Hin Hui, Keith Wan-Hang Chiu, Philip Leung-Ho Yu, et al.
Hepatology International|June 10, 2025
Emerging therapies for HBsAg seroclearance: spotlight on novel combination strategiesRex Wan-Hin Hui, James Fung, Wai-Kay Seto, et al.
Clinical and Molecular Hepatology|January 19, 2023
The role of different viral biomarkers on the management of chronic hepatitis BLung-Yi Mak, Rex Wan-Hin Hui, James Fung, et al.
Pageof 33